ロード中...
Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the use of drugs with a mechanism of action a...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3401131/ https://ncbi.nlm.nih.gov/pubmed/22826792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2012.e10 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|